Weight Loss Composition and Metabolic Adaptation During Hypocaloric Dieting
The Relationship Between Weight Loss Composition, Body Composition Changes, and Metabolic Adaptation During a Hypocaloric Dietary Intervention
1 other identifier
interventional
150
0 countries
N/A
Brief Summary
Weight loss induced by hypocaloric dietary interventions is commonly accompanied by reductions in resting metabolic rate (RMR), a phenomenon often described as metabolic adaptation. The magnitude of this decline varies substantially between individuals and may depend not only on the amount of weight lost but also on the composition of weight loss, particularly the relative contributions of fat mass and fat-free mass. This prospective interventional study will investigate whether changes in body composition during a hypocaloric dietary intervention are associated with changes in RMR and metabolic adaptation. Approximately 150 adults with overweight or obesity will participate in a structured dietary program designed to induce moderate energy restriction. Body composition and resting metabolic rate will be assessed before and after the intervention to evaluate associations between fat mass loss, fat-free mass loss, and metabolic responses to weight reduction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Jun 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 4, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
June 4, 2026
May 1, 2026
1.5 years
May 31, 2026
May 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Resting Metabolic Rate
Change in resting metabolic rate (RMR) measured by indirect calorimetry between baseline and post-intervention assessment.
Baseline to end of dietary intervention (up to 12 months)
Secondary Outcomes (6)
Change in Fat Mass
Baseline to end of dietary intervention (up to 12 months)
Change in Fat-Free Mass
Baseline to end of dietary intervention (up to 12 months)
Change in Body Weight
Baseline to end of dietary intervention (up to 12 months)
Change in Abdominal Circumference
Baseline to end of dietary intervention (up to 12 months)
Intervention Duration
Baseline to end of intervention (up to 12 months)
- +1 more secondary outcomes
Study Arms (1)
Hypocaloric Dietary Intervention
EXPERIMENTALParticipants will follow individualized hypocaloric dietary plans designed to produce a moderate daily energy deficit based on measured resting metabolic rate. The intervention focuses on dietary energy restriction while supporting preservation of fat-free mass through adequate protein intake. Body composition and resting metabolic rate will be assessed before and after the intervention to evaluate metabolic responses to weight loss.
Interventions
Participants will follow individualized dietary plans designed to produce an energy deficit of approximately 500-600 kcal/day relative to measured resting metabolic rate. Protein intake will be prescribed at approximately 1.5 g/kg body weight per day to support preservation of fat-free mass. Dietary plans will be adjusted as needed during the intervention period, and participants will attend regular follow-up visits to monitor progress and adherence.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years and older.
- Individuals living with overweight or obesity.
- Willingness and ability to comply with dietary recommendations and study procedures.
- Provision of written informed consent.
You may not qualify if:
- Diagnosed metabolic or endocrine disorders known to affect energy expenditure.
- Use of medications known to substantially affect metabolism or body composition.
- Pregnancy or breastfeeding.
- Any medical condition that, in the opinion of the investigators, precludes safe participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yftach Gepner, PhD
Tel Aviv University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator - Professor
Study Record Dates
First Submitted
May 31, 2026
First Posted
June 4, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
June 4, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share